Procept BioRobotics down 8% on Intuitive Surgical 510(k) clearance
Lemon_tm

Procept BioRobotics (NASDAQ:PRCT) is off 8% in Wednesday morning trading after rival Intuitive Surgical (NASDAQ:ISRG) announced after the bell Tuesday it received US FDA 510(k) clearance for its da Vinci SP surgical system for prostatectomy.
The procedure is for removal of a non-cancerous prostate in advanced benign prostate hyperplasia (BPH).

Procept (PRCT) offers the Aquablation system for BPH.
Despite the new competition, Wells Fargo's analyst Nathan Treybeck said he doesn't see a near or middle-term impact on Aquablation procedures. He has an outperform rating on Procept (PRCT).
Intuitive (ISRG) "is in early stages of its launch plan" Treybeck noted, adding the company "will need clinical data to drive surgeon adoption."
Intuitive Surgical is up ~12% in Wednesday morning trading.
Read why Seeking Alpha contributor Mike Zaccardi is bullish on Intuitive (ISRG).